CATHAY SECURITIES CORPORATION GLOBAL GENOMICS IMMUNOLOGY & MEDICAL REVCATHAY SECURITIES CORPORATION GLOBAL GENOMICS IMMUNOLOGY & MEDICAL REVCATHAY SECURITIES CORPORATION GLOBAL GENOMICS IMMUNOLOGY & MEDICAL REV

CATHAY SECURITIES CORPORATION GLOBAL GENOMICS IMMUNOLOGY & MEDICAL REV

Inga transaktioner
Se i superdiagram

Nyckeltal

Assets under management (AUM)
‪1.88 B‬TWD
Fund flows (1Y)
‪−547.32 M‬TWD
Dividend yield (indicated)
Discount/Premium to NAV

Om CATHAY SECURITIES CORPORATION GLOBAL GENOMICS IMMUNOLOGY & MEDICAL REV

Issuer
Cathay Financial Holdings Co., Ltd.
Brand
Cathay
Expense ratio
1.05%
Inception date
22 nov. 2021
Index tracked
Solactive Global Genomics Immunology and Medical Revolution Index - Benchmark TR Net
Management style
Passive
ISIN
TW0000089804

Classification

Asset Class
Equity
Kategori
Sektor
Focus
Sjukvård
Niche
Utrustning och tjänster för hälsovård
Strategi
Vanilj
Weighting scheme
Börsvärde
Selection criteria
Börsvärde

Returns

1 månad3 månaderHittills i år1 år3 år5 år
Price performance
NAV total return

What's in the fund

As of 26 juni 2024
Exposure type
AktierBonds, Cash & Other
Hälsoteknik
Aktier99.13%
Hälsoteknik95.97%
Hälsotjänster1.72%
Kommersiella tjänster1.44%
Bonds, Cash & Other0.87%
Likvida medel0.87%
Stock breakdown by region
84%12%3%
Nordamerika84.47%
Europa12.05%
Asien3.47%
Latinamerika0.00%
Afrika0.00%
Mellanöstern0.00%
Oceanien0.00%
Top 10 holdings

Utdelningar

Utdelningshistorik

Assets under management (AUM)

Fund Flows